Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Chang-Yao Chu"'
Autor:
Chun-Hua Hung, Shang-Yin Wu, Cheng-I Daniel Yao, Hsuan-Heng Yeh, Chien-Chung Lin, Chang-Yao Chu, Tzu-Yu Huang, Meng-Ru Shen, Chun-Hung Lin, Wu-Chou Su
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-24 (2024)
Abstract The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosyla
Externí odkaz:
https://doaj.org/article/3a5cd2f7ff2f4570954e24e9d5764b19
Autor:
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The role of Programmed Cell Death Ligand 1 (PD-L1) expression in predicting epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) efficacy remains controversial. Recent studies have highlighted that tumor-intrinsic PD-L1 sig
Externí odkaz:
https://doaj.org/article/83cd94bc8c05488fbcc304f0efe0162e
Autor:
Po-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, Yi-Lin Chen, Wan-Li Chen, Kuan-Yu Lin, Chung-Liang Ho, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Yi-Lin Wu, Yau-Lin Tseng, Chao-Chun Chang, Yi-Ting Yen, Chia-Ying Lin, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Neoadjuvant immunotherapy and chemotherapy have improved the major pathological response (MPR) in patients with early-stage operable non-small cell lung cancer (NSCLC). This study aimed to assess whether the presence of targetable driver mut
Externí odkaz:
https://doaj.org/article/249de0c14737440c9d0617b01e951b12
Publikováno v:
Thoracic Cancer, Vol 12, Iss 22, Pp 3068-3071 (2021)
Abstract C‐ros oncogene 1 receptor tyrosine kinase (ROS1) rearrangement has been detected in patients with advanced non‐small cell lung cancer (NSCLC). Although ROS1 tyrosine kinase inhibitors (TKIs) provide a survival benefit for patients with R
Externí odkaz:
https://doaj.org/article/ed32ab372512427db583dba7cab3a7cf
Autor:
Chao-Chun Chang, Chia-Ying Lin, Chang-Yao Chu, Yi-Cheng Hsiung, Ming-Tsung Chuang, Yau-Lin Tseng, Yi-Ting Yen
Publikováno v:
Cancer Imaging, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Recent advance in tissue characterization with parametric mapping imaging has the potential to be a novel biomarker for histopathologic correlation with thymic epithelial tumors (TETs). The purpose of our study is to evaluate MRI
Externí odkaz:
https://doaj.org/article/a85b60ec846c4e7e95835fd308c9db02
Autor:
Chih-Chieh Yen, Wei-Li Huang, Sin-Syue Li, Ya-Ping Chen, Yau-Lin Tseng, Yi-Ting Yen, Chang-Yao Chu, Ya-Ting Hsu, Tsai-Yun Chen
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Thymoma-associated haematological diseases (HDs), such as pure red cell aplasia (PRCA) and Good's syndrome, are extremely rare, and due to the paucity of large-scale studies, the characteristics, remission after thymectomy, and long-term
Externí odkaz:
https://doaj.org/article/77ab434f659a402ba4f7b4e69f25b5b0
Autor:
Chia-Ying Lin, Chao-Chun Chang, Chang-Yao Chu, Li-Ting Huang, Ta-Jung Chung, Yi-Sheng Liu, Yi-Ting Yen
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Adequate and representative tissue from lung tumor is important in the era of precision medicine. The aim of this study is to identify detailed procedure-related variables and factors influencing diagnostic success and tissue adequacy for
Externí odkaz:
https://doaj.org/article/282d928424084e6aa950275eea057eb4
Autor:
Shu-Hsien Wang, Po-Min Chiang, Yung-Yeh Su, Yu-Ting Yu, Ya-Ping Chen, Tsai-Yun Chen, Medeiros, L. Jeffrey, Chang-Yao Chu, Peng-Chieh Chen, Kung-Chao Chang
Publikováno v:
American Journal of Surgical Pathology; Nov2024, Vol. 48 Issue 11, p1425-1438, 14p
Publikováno v:
Acta Ophthalmologica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec529747c8cbeec8ad524d8cb6de319d
https://doi.org/10.1111/aos.15635
https://doi.org/10.1111/aos.15635
Autor:
Chia Jui Yen, I-Ting Liu, Ming-Yu Chang, Hung Wen Tsai, Ya-Fu Hou, Chia-Sheng Yen, Chang-Yao Chu, Wen-Lung Wang
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5323, p 5323 (2021)
Volume 13
Issue 21
Cancers, Vol 13, Iss 5323, p 5323 (2021)
Volume 13
Issue 21
Simple Summary Hepatocellular carcinoma (HCC) is the third most commonly diagnosed cancer in the world, and surgical resection is the commonly used curative management of early-stage disease. However, the recurrence rate is high after resection, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c666d0c9ea724da1ddf8f2395aac052c
http://europepmc.org/articles/PMC8582529
http://europepmc.org/articles/PMC8582529